Sporadic late‐onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-4598|51|6|934-935

ISSN： 0148-639x

Source： MUSCLE AND NERVE, Vol.51, Iss.6, 2015-06, pp. : 934-935

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sporadic late‐onset nemaline myopathy as a rare cause of slowly progressive muscle weakness with young adult onset

By  

MUSCLE AND NERVE, Vol. 51, Iss. 5, 2015-05 ,pp. : 772-774

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 1, 2015-10 ,pp. : 52-59

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 1, 2015-10 ,pp. : 52-59

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : 1106-1110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin

By  

Acta Haematologica, Vol. 137, Iss. 3, 2017-03 ,pp. : 123-131

Karger

Access to resources Recommend Favorite